Physician profile
Maureen C Roller
NPI 1063588853
$1,345.19
in general payments reported to CMS, 2019-2025
23 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $322 · 2023: $271 · 2024: $414 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $236.17 | 2024 | Gemtesa |
| Novo Nordisk INC | $189.01 | 2021-2023 | Rybelsus, Ozempic |
| Vanda Pharmaceuticals INC. | $173.20 | 2021-2023 | Hetlioz, Fanapt |
| Tactile Systems Technology INC | $100.75 | 2025 | Nimbl, Flexitouch Plus |
| Amgen INC. | $97.41 | 2022-2024 | Repatha, Otezla |
| Abbvie INC. | $69.36 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $50.20 | 2024 | Breztri, Lokelma, Airsupra |
| Amarin Pharma, INC. | $45.11 | 2021-2022 | |
| Esperion Therapeutics, INC. | $39.20 | 2024 | Nexletol |
| Phathom Pharmaceuticals, INC. | $37.22 | 2023-2024 | Voquezna |
| Medicomp INC | $34.91 | 2025 | Telepatch Cardiac Monitor |
| Mylan Specialty L.P. | $31.78 | 2023 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.01 | 2023 | Jardiance |
| Ani Pharmaceuticals, INC. | $25.82 | 2025 | Purified Cortrophin Gel |
| Redhill Biopharma INC. | $24.23 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $23.21 | 2022 | |
| Lundbeck LLC | $22.72 | 2025 | Rexulti |
| Pfizer INC. | $21.84 | 2025 | |
| Scilex Pharmaceuticals INC. | $21.04 | 2022 | |
| Exact Sciences Corporation | $20.83 | 2023 | Cologuard Collection Kit |
| Alk-Abello, INC | $19.06 | 2024 | Grastek, Ragwitek, Odactra |
| Lilly USA, LLC | $18.80 | 2023 | Mounjaro |
| Merck Sharp & Dohme LLC | $13.31 | 2023 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Roller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.